Skip to content

The clinical study of the treatment of Spine tumor with Cyberknife

The clinical study of the treatment of Spine tumor with Cyberknife

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-17013946
Enrollment
Unknown
Registered
2017-12-15
Start date
2017-12-16
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spine tumor

Interventions

1:Cyberknife

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with primary or metastatic tumors of Spine tumors

Exclusion criteria

Exclusion criteria: 1. Local lesions are not suitable for SRS; 2. Body poor constitution could not accept SRS.

Design outcomes

Primary

MeasureTime frame
local control and toxcity;

Countries

China

Contacts

Public ContactHongqing Zhuang

Peking University Third Hospital

yiduzhengmu@163.com+86 13051776232

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026